One of the most repeated claims in the longevity supplement space is that NAD+ levels fall by roughly half between young adulthood and middle age. It is stated confidently on product pages, in podcast interviews, and across hundreds of health websites. The underlying biology is real — NAD+ does decline with age in important tissues — but the full picture is considerably more nuanced than that single statistic suggests. Where NAD+ falls, how much it falls, and what that decline actually means for your health depends on which tissue you are measuring, how you are measuring it, and what else is happening in the body at the same time. This article covers what the research genuinely shows, including findings that complicate the standard narrative.
NAD+ Decline Is Real but Not Uniform Across All Tissues
The evidence for age-related NAD+ decline is strongest in specific tissues: skin, skeletal muscle, brain, and fat tissue. Blood is a different story, and the distinction matters more than most supplement-focused coverage acknowledges.
Studies measuring NAD+ in human tissue samples have found meaningful age-related reductions in several locations. Research published in PLOS ONE (Massudi et al., 2012) examined human skin tissue across a wide age range and found a strong negative correlation between NAD+ levels and age in males, with post-pubescent females showing a similar though somewhat different pattern. Muscle tissue has also shown consistent age-related decline: a study by Janssens et al. (2022) measuring skeletal muscle biopsies from younger and older adults found significantly lower NAD+ in the older group, with physically impaired older adults showing the lowest levels of all. Brain NAD+ appears to follow a similar trajectory, with multiple studies reporting lower levels in older individuals, particularly after midlife.
What the Skin Research Shows
Human skin has been one of the more accessible tissues for NAD+ research because samples can be obtained without invasive procedures. The Massudi et al. data showed that NAD+ concentrations in skin declined significantly with age in males across a range of 15 to 77 years, with a strong statistical correlation. The pattern in females was present but less linear, which researchers have suggested may reflect differences in NAD+ recycling efficiency between sexes — a question that remains under active investigation. What is clear is that skin NAD+ does not stay stable across a lifetime, and the decline accelerates in the decades after early adulthood.
What the Muscle Research Shows
Skeletal muscle is arguably the most functionally significant tissue for understanding NAD+ and aging, because muscle health is so closely tied to physical independence, metabolic rate, and overall longevity. The Janssens et al. research is particularly notable because it controlled for physical activity levels — a critical methodological point, since older adults tend to be less active, and inactivity itself depletes NAD+. Even accounting for this, older adults in their study showed lower muscle NAD+ than younger controls. Notably, athletic older adults had muscle NAD+ levels comparable to younger individuals, which suggests physical activity plays a meaningful role in maintaining tissue NAD+ with age. This finding connects directly to the lifestyle content in our article on exercise and NAD+.
The Blood NAD+ Story Is More Complicated
Most commercial NAD+ testing measures NAD+ in blood, partly because blood is easy to collect. For years, studies using blood samples reported age-related declines, which became the basis for the widely cited claim that NAD+ drops dramatically with age. More recent and more rigorously designed research has challenged this picture, at least for blood specifically.
A study published in Nature Metabolism in 2026, using highly validated measurement methods across seven independent human cohorts, found that whole-blood NAD+ levels remained remarkably stable across age groups and were not significantly changed by lifestyle interventions. This does not mean NAD+ decline with aging is a myth — the tissue-level data discussed above is real — but it does mean that blood NAD+ may not be a reliable indicator of what is happening inside muscles, the brain, or other organs where the aging-relevant changes are actually occurring. As one research summary put it, blood is easy to collect, but it does not necessarily reflect what is happening in the tissues where aging processes unfold.
The practical implication is worth stating directly: if you test your blood NAD+ levels and get a normal result, that does not guarantee your muscle or brain NAD+ is also normal. Conversely, a low blood reading may not perfectly predict tissue-level depletion either. We cover the testing question in more depth in our article on how to test your NAD+ levels.
Why NAD+ Falls: The Supply-and-Demand Problem
Understanding why NAD+ declines requires looking at both sides of the equation. The body produces NAD+ through several biosynthetic pathways, and it is simultaneously consumed by enzymes that depend on it for their function. In younger, healthier cells, production keeps pace with consumption. As the body ages, this balance shifts in ways that compound each other.
Declining Production Efficiency
The primary route by which most cells maintain their NAD+ supply is through an enzyme called NAMPT (nicotinamide phosphoribosyltransferase), which recycles nicotinamide — a byproduct of NAD+ consumption — back into usable NAD+. Research suggests that NAMPT activity declines with age and with cellular senescence, meaning the recycling machinery becomes less efficient precisely when the demand on it is increasing. The body also has a pathway to synthesize NAD+ from tryptophan, an amino acid obtained through diet, but this route is less efficient and more metabolically costly.
Accelerating Consumption by CD38 and PARP
On the consumption side, two enzymes become significantly more active with age. CD38, which breaks down NAD+ to generate cellular signaling molecules, increases in both activity and tissue abundance as we get older. Research by Camacho-Pereira et al. (2016) identified CD38 as a primary driver of age-related NAD+ decline. Critically, CD38 activity is also stimulated by inflammation — and the chronic low-grade inflammation that tends to accompany aging, sometimes called “inflammaging,” creates a self-reinforcing loop: more inflammation drives more CD38 activity, which depletes more NAD+, which impairs the sirtuin-mediated pathways that would otherwise help resolve inflammation. The CD38 connection is explored more fully in our article on the CD38 problem.
PARP enzymes, which are your cells’ first responders to DNA damage, also consume substantial amounts of NAD+ in the repair process. As DNA damage accumulates with age — from oxidative stress, UV exposure, environmental toxins, and replication errors — PARP activity increases accordingly, placing additional demand on an already shrinking NAD+ supply.
Lifestyle Factors That Accelerate the Decline
Beyond the biological changes that accompany aging, several common lifestyle factors independently deplete NAD+ or impair its production. Alcohol metabolism is particularly significant: the liver uses NAD+ extensively to process alcohol, and chronic or heavy drinking can meaningfully reduce available NAD+. Sleep deprivation disrupts the circadian regulation of NAD+ biosynthesis enzymes, since NAD+ production is partly governed by the body’s internal clock. Chronic stress elevates cortisol and promotes inflammation, both of which increase NAD+ consumption. A diet high in refined carbohydrates and fats places additional metabolic demands on NAD+-dependent pathways. Each of these factors is covered in its own article in our Lifestyle section.
What the Decline Actually Means for How You Feel and Function
The biological consequences of lower NAD+ in key tissues are not purely theoretical. While it is important not to overstate the causal links — much of the evidence still comes from animal models or small human studies — there is a plausible and increasingly well-supported connection between tissue NAD+ decline and several features of aging that most people experience directly.
Reduced mitochondrial efficiency as NAD+ falls is consistent with the fatigue and reduced stamina that become more common from middle age onward. Impaired DNA repair capacity from lower PARP substrate availability is consistent with the accumulation of cellular damage over time. Reduced sirtuin activity, which depends entirely on NAD+ as a fuel, is consistent with impaired stress response, altered gene expression, and declining metabolic flexibility. None of these relationships is simple or proven by NAD+ decline alone, but taken together they form a coherent picture of why maintaining NAD+ levels has attracted serious scientific interest as a potential strategy for supporting healthy aging.
For a detailed look at the sirtuin connection specifically, see our article on the sirtuin theory of aging. For the mitochondrial angle, see mitochondria and aging.
Can You Slow or Reverse the Decline?
This is the central practical question, and the honest answer is: possibly, to a meaningful degree, through a combination of lifestyle and supplementation — though the human evidence is still accumulating. The Janssens muscle research mentioned earlier is instructive here: physically active older adults maintained NAD+ levels similar to younger individuals, suggesting that the decline is not entirely inevitable and that behavior matters. Animal studies have consistently shown that supplementation with NAD+ precursors such as NMN and NR can restore tissue NAD+ levels, and human trials have confirmed that both compounds raise NAD+ in blood and, in at least some studies, in muscle tissue as well.
What the evidence does not yet support is the claim that any intervention can fully restore the NAD+ levels of a 60-year-old to those of a 25-year-old, or that doing so would necessarily translate into dramatically extended lifespan. The more defensible claim is that supporting NAD+ levels through proven precursors, combined with lifestyle factors that reduce unnecessary depletion, is a reasonable strategy for maintaining the cellular functions that NAD+ enables. Our complete NMN guide and complete NR guide cover the supplementation options in detail, and our beginner’s stack guide is a good starting point if you are considering supplementation for the first time.
What the Current Research Picture Tells Us
The story of NAD+ and aging is more interesting and more honest than the simplified version most sites present. NAD+ does decline with age in the tissues that matter most — muscle, brain, and skin — and the mechanisms behind that decline are increasingly well understood. The blood picture is more complicated, and recent high-quality research suggests that blood NAD+ may not be the reliable aging biomarker it was assumed to be.
What is not in dispute is that the enzymes NAD+ fuels — sirtuins, PARP, and others — are genuinely important to cellular health, and that their function depends on NAD+ availability. The question of whether supplementing with NAD+ precursors meaningfully preserves or restores those functions in aging humans is the right question to be asking, and it is one that ongoing clinical research is working to answer. We will cover those trial results as the evidence develops.
The next article in this series goes deeper on the mechanics: The NAD+ Pathway Explained: From NMN to NAD+ to NADH.
Frequently Asked Questions About NAD+ Levels and Aging
By How Much Does NAD+ Decline With Age?
The commonly cited figure — roughly a 50% decline by middle age — comes primarily from animal studies and limited human tissue data. In specific tissues such as skin and skeletal muscle, meaningful age-related declines have been documented in humans. However, recent well-controlled research has found that whole-blood NAD+ does not show a consistent age-related decline, suggesting the picture varies significantly depending on which tissue is being measured and how.
Does NAD+ Decline Happen at the Same Rate in Everyone?
No. The rate of NAD+ decline appears to be influenced by lifestyle factors including physical activity, sleep quality, alcohol consumption, diet, and the presence of chronic inflammation. Research suggests that physically active older adults maintain significantly higher muscle NAD+ levels than sedentary peers, indicating that the decline is not simply a fixed feature of chronological aging.
Is Lower NAD+ a Cause of Aging or Just Associated With It?
This is one of the central unresolved questions in the field. The relationship is almost certainly bidirectional: aging creates conditions that deplete NAD+, and lower NAD+ impairs the cellular functions — DNA repair, mitochondrial efficiency, sirtuin activity — that would otherwise slow biological aging. Whether declining NAD+ is a primary driver of aging or primarily a consequence of it remains an active area of research.
Does Measuring Blood NAD+ Tell You Whether Your Cells Are Depleted?
Not reliably. Recent research published in Nature Metabolism found that whole-blood NAD+ levels remain stable across age groups and are not clearly changed by lifestyle interventions — while tissue-level declines in muscle and brain have been documented. Blood is practical to measure but may not reflect what is happening in the tissues most relevant to aging. This limits the usefulness of blood-based NAD+ tests as a direct measure of cellular NAD+ status.
What Is the Fastest Way to Deplete NAD+ Levels?
Several factors accelerate NAD+ depletion beyond normal aging: heavy or chronic alcohol consumption, which uses NAD+ extensively in liver metabolism; significant acute DNA damage from UV radiation or toxin exposure, which triggers PARP-mediated consumption; chronic inflammation, which drives CD38 activity; and severe sleep deprivation, which disrupts the circadian regulation of NAD+ biosynthesis. These factors compound each other and can accelerate the decline beyond what aging alone would produce.